Western Standard LLC’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Western Standard LLC’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-109,545	Closed	-$2.64M	–	45
2023 Q1	$2.64M	Buy	+109,545	New	+$1.37M	2.68%	12

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Western Standard LLC's PRVB Position: Q2 2023 in Review

Western Standard LLC sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 109,545 shares — an estimated $2.64M sold.

Western Standard LLC first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $2.64M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Western Standard LLC reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Western Standard LLC sold 109,545 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $2.64M.
Western Standard LLC first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Western Standard LLC's Provention Bio, Inc. Common Stock position peaked at $2.64M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Western Standard LLC's 13F filing for Q2 2023, filed 14 Aug 2023.